Dollar eases as vaccine trials lift risk appetite

19.05.2020 - Korneychuk Evgeniya
Dollar eases as vaccine trials lift risk appetite

The dollar bounced on Tuesday after the COVID-19 vaccine trial reported encouraging data, lifting market appetite for risky currencies.

The euro surged against the dollar and the Swiss franc after Germany and France proposed for a 500 billion euro recovery fund for European regions hardest hit by the pandemic.

Commodity currencies and risky assets also rallied. This came after oil prices rebounded from losses and as U.S. drugmaker Moderna reported positive data from their initial vaccine trials.

The euro stood at 1.0911 against the dollar on Tuesday, while the British pound climbed to $1.2206.

The dollar traded at 107.44 on the yen.

Despite the positive market mood, the resurgence of coronavirus infections in certain parts of the world still worried investors.

In the onshore market, the Chinese yuan steadied at 7.1069 on the dollar. However, currency traders remain wary amid the rising conflict between China and the United States.

The Australian dollar stood at $0.6527, nearing a one-week high, while the New Zealand dollar traded at $0.6042. 

Risk disclaimer "Market Solutions Ltd – Suite 305 Griffith Corporate Centre P.O. Box 1510 Beachmont, Kingstown, St Vincent and the Grenadines is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0128 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of Market solutions Ltd and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from umarkets.ai or Market Solutions limited." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue
×

Help with deposit?